Wealth Enhancement Advisory Services, LLC Repligen Corp Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Repligen Corp stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 3,926 shares of RGEN stock, worth $477,951. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,926
Previous 4,118
4.66%
Holding current value
$477,951
Previous $523,000
6.69%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RGEN
# of Institutions
495Shares Held
57.4MCall Options Held
75.6KPut Options Held
521K-
Black Rock Inc. New York, NY7.57MShares$921 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.57MShares$921 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$618 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$206 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.67MShares$204 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.76B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....